Showing results (371-380 of 533) with videos related to

Sort By:
Pageof 54
Expert Review of Pharmacoeconomics & Outcomes Research|May 31, 2023
Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trialLinus Jönsson, Stephane A Regnier, Steven Kymes, et al.
Lancet (London, England)|October 27, 2018
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b studyUwe Reuter, Peter J Goadsby, Michel Lanteri-Minet, et al.
Acta Neurochirurgica|January 26, 2024
Management of cervical CSF-venous fistula causing acute cognitive impairment and comaLalani Carlton Jones, Jan Hoffmann, Saamir Mohideen, et al.
Annals of Clinical and Translational Neurology|March 11, 2020
Insular and occipital changes in visual snow syndrome: a BOLD fMRI and MRS studyFrancesca Puledda, Dominic Ffytche, David J Lythgoe, et al.
Neurobiology of Pain (Cambridge, Mass.)|June 22, 2019
Sex differences in the expression of calcitonin gene-related peptide receptor components in the spinal trigeminal nucleusYadong Ji, Alexandra Rizk, Pamela Voulalas, et al.
Brain : a Journal of Neurology|May 28, 2019
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migrainePeter J Goadsby, Linda A Wietecha, Ellen B Dennehy, et al.
Cephalalgia : an International Journal of Headache|January 20, 2017
Neck-Tongue syndrome: A systematic reviewAmy A Gelfand, Hannah Johnson, Marc Ep Lenaerts, et al.
Neurology|September 11, 2020
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized studyPeter J Goadsby, Stephen D Silberstein, Paul P Yeung, et al.
The New England Journal of Medicine|August 18, 2021
Atogepant for the Preventive Treatment of MigraineJessica Ailani, Richard B Lipton, Peter J Goadsby, et al.
Cephalalgia : an International Journal of Headache|June 26, 2019
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trialDavid W Dodick, Richard B Lipton, Stephen Silberstein, et al.
Pageof 54